Role of mitochondrial microRNAs (mitomiRs) in endogenous renal repair
线粒体 microRNA (mitomiRs) 在内源性肾修复中的作用
基本信息
- 批准号:10471652
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-17 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAttenuatedBiogenesisBiological AssayCell NucleusCell physiologyCellsCharacteristicsCytosineCytosolDataDeteriorationDevelopmentDioxygenasesDiseaseElderlyEnd stage renal failureEnhancersEnzymesEpigenetic ProcessEpithelial CellsExhibitsFamily suidaeFibrosisFunctional ImagingFunctional disorderGene ExpressionGene SilencingGenesGenetic TranscriptionHarvestHistonesHypertensionImaging TechniquesImpairmentIn VitroInflammationInfusion proceduresInjury to KidneyKidneyKidney DiseasesMeasuresMediatingMethylationMicroRNAsMitochondriaMitochondrial DNAMorbidity - disease rateNucleic Acid Regulatory SequencesOxidation-ReductionPhenotypePolyribonucleotide NucleotidyltransferasePopulationProcessProductionProliferatingProtein ImportRegulator GenesRenal Artery StenosisRenal functionRibonuclease IIIRoleStructural defectStructureSystemTechniquesTestingTubular formationUntranslated RNAcell injuryclinically relevantexperimental studygenome-wideimprovedin vivoinhibitor/antagonistinjuredinsightkidney repairmigrationmortalitynovelnovel strategiesoxidationparacrineporcine modelpreservationprogenitorpromoterprotective effectrenal ischemiarepairedreparative capacitytool
项目摘要
Renal artery stenosis (RAS) remains a common cause of hypertension and end-stage renal disease in the
elderly population, associated with increased morbidity and mortality. Recent data suggest that renal ischemia
in RAS interferes with endogenous kidney repair mechanisms, such as CD133+/CD24+ scattered tubular-like
cells (STCs), which can proliferate and their progeny re-differentiate into tubular epithelial cells to replace lost
neighboring injured tubular cells. Our previous studies have shown that experimental RAS impairs the
reparative capacity of swine STCs by inducing structural and functional abnormalities in their mitochondria.
However, the processes underpinning RAS-induced STC mitochondrial damage remain unclear.
Micro-RNAs (miRNAs) are non-coding RNA fragments that function as post-transcriptional regulators of
gene expression. MiRNA genes are transcribed in the nucleus, which results in the production of pri- and pre-
miRNA precursors, and subsequently mature miRNAs. Although most mature miRNAs are present in the
cytosol, few miRNAs, known as ‘mitomiRs’, translocate to the mitochondrion to silence gene expression related
to mitochondrial functions.
Our preliminary data show that RAS increases expression of mitomiRs in swine STCs, associated with
decreased expression of mitochondrial DNA (mtDNA) genes, and in turn mitochondrial structural abnormalities
and dysfunction. Our pilot experiments also show that the promoters and enhancers of mitomiRs exhibit hyper
5-hydroxymethylation of cytosine (5hmC), an epigenetic mark generated by the oxidation of 5mC by the ten-
eleven translocation methylcytosine dioxygenase (TET). Possibly, renal ischemia in RAS may alter mitomiR
biogenesis and interfere with mitochondrial function in STCs. This might be partly mediated by epigenetic
processes (5hmC) within mitomiR regulatory regions and/or increased import of mitomiRs into mitochondria.
The working hypothesis underlying this proposal is that altered mitomiR expression in STCs underlies
RAS-induced STC mitochondrial damage, blunting the paracrine function and capacity of STCs to
preserve the post-stenotic kidney. Three specific aims will be pursued: Aim 1: will test whether increased
mitomiR expression in RAS-STCs induces mitochondrial structural damage and dysfunction in STCs. Aim 2:
will test whether RAS imposes epigenetic changes that increase mitomiR expression in STCs. Aim 3: will test
whether aberrant mitomiR mitochondrial import contributes to STC dysfunction. Successful studies will provide
novel insight into the vulnerability of this repair system and may contribute towards development of feasible
clinically relevant tools for improving the utility and efficacy of kidney repair in renal disease.
肾动脉狭窄(RAS)仍然是高血压和终末期肾病的常见原因,
老年人口,与发病率和死亡率增加有关。最近的数据表明,肾缺血
RAS干扰内源性肾脏修复机制,如CD 133 +/CD 24+分散的肾小管样
细胞(STC),可以增殖,其后代再分化为肾小管上皮细胞,以取代失去的
邻近受损的肾小管细胞。我们以前的研究表明,实验RAS损害了
通过诱导线粒体结构和功能异常来增强猪STC的修复能力。
然而,RAS诱导的STC线粒体损伤的基础过程仍不清楚。
微RNA(micro-RNAs,miRNAs)是一种非编码RNA片段,在转录后调节基因的转录,
基因表达。miRNA基因在细胞核中转录,这导致产生初级和前初级RNA。
miRNA前体和随后成熟的miRNA。虽然大多数成熟的miRNAs存在于
在细胞质中,很少有称为“mitomiR”的miRNAs易位到细胞质中,以沉默相关基因的表达。
线粒体的功能。
我们的初步数据表明,RAS增加猪STC中mitomiRs的表达,与
线粒体DNA(mtDNA)基因表达减少,进而导致线粒体结构异常
和功能障碍。我们的初步实验还表明,mitomiRs的启动子和增强子表现出高表达,
5-胞嘧啶(5 hmC)的羟甲基化,这是一种表观遗传标记,是由10-
十一易位甲基胞嘧啶双加氧酶(泰特)。RAS中的肾缺血可能改变mitomiR
生物合成和干扰STC中的线粒体功能。这可能部分由表观遗传介导
在mitomiR调控区域内的5 hmC过程和/或增加mitomiR向线粒体的输入。
支持这一建议的工作假设是STC中mitomiR表达的改变是STC的基础。
RAS诱导STC线粒体损伤,钝化STC的旁分泌功能和能力,
保留狭窄后的肾脏将追求三个具体目标:
RAS-STC中的mitomiR表达诱导STC中的线粒体结构损伤和功能障碍。目标二:
将测试RAS是否施加增加STC中mitomiR表达的表观遗传变化。目标3:意志测试
异常的mitomiR线粒体输入是否有助于STC功能障碍。成功的研究将提供
新的见解,这种修复系统的脆弱性,并可能有助于发展可行的
临床相关工具,用于改善肾脏疾病中肾脏修复的效用和功效。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alfonso Eirin其他文献
Alfonso Eirin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alfonso Eirin', 18)}}的其他基金
Role of mitochondrial microRNAs (mitomiRs) in endogenous renal repair
线粒体 microRNA (mitomiRs) 在内源性肾修复中的作用
- 批准号:
10583380 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Obesity-induced dysfunction of human MSC in peripheral microvascular repair
肥胖引起的人间充质干细胞在外周微血管修复中的功能障碍
- 批准号:
10516515 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Obesity-induced dysfunction of human MSC in peripheral microvascular repair
肥胖引起的人间充质干细胞在外周微血管修复中的功能障碍
- 批准号:
10653231 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Mitochondrial injury interferes with endogenous renal repair in experimental renovascular disease
线粒体损伤干扰实验性肾血管疾病的内源性肾修复
- 批准号:
9805789 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
A potential role for mitoprotection in preserving the kidney in metabolic syndrome and renal artery stenosis
有丝分裂保护在代谢综合征和肾动脉狭窄中保护肾脏的潜在作用
- 批准号:
9115146 - 财政年份:2015
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Research Grant